Trials / Completed
CompletedNCT00976612
Nilotinib Pharmacokinetics (PK) in Gastrointestinal Stromal Tumor (GIST): Nilotinib PK
Pharmacokinetic Study of Nilotinib in Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Showing Failure to Both Imatinib and Sunitinib
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
In patients who are receiving nilotinib, nilotinib plasma levels will be measured after 1 month of nilotinib treatment. The relationship between surgery type and nilotinib pharmakokinetic properties will be investigated in this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nilotinib | Nilotinib 400mg bid daily |
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2011-08-01
- Completion
- 2011-12-01
- First posted
- 2009-09-14
- Last updated
- 2020-01-07
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00976612. Inclusion in this directory is not an endorsement.